Cost-effectiveness of prostate cancer chemoprevention: A quality of life-years analysis

Medicine and Dentistry

• Prostate Cancer 100%
• Health Care Cost 100%
• Cost-Effectiveness Analysis 100%
• Pilus 83%
• Chemoprophylaxis 66%
• Quality Adjusted Life Year 50%
• Analysis 50%
• Quality of Life 50%
• Prevalence 33%
• Cancer Prevention 33%
• Risk Reduction 33%
• High Risk Population 33%
• Sensitivity Analysis 33%
• Man 33%
• Adjustment 33%
• Neoplasm 16%
• Health Status 16%
• Lifespan 16%
• Prostate Hypertrophy 16%
• 3 (4 Amino 1,1 Dimethylbutyl) 6 (1 Hydroxyethyl)oxapenem 3 Carboxylic Acid 16%
• Surveillance, Epidemiology, and End Results 16%
• Age 16%
• Survival 16%
• Health 16%
• Incidence 16%
• Chemoprevention 16%
• Placebo 16%